postoperatively , this blunting disappeared in the cured patients ( l-dopa , 49.1 +/- 3.5 % ; carbidopa/l-dopa , 56.3 +/- 5.1 % ) , but the blunting persisted in the uncured patients ( l-dopa , 49.3 +/- 7.9 % ; carbidopa/l-dopa , 69.3 +/- 4.2 % ) .
C0023570
l-dopa
C0353697
carbidopa/l-dopa